FY2021
Consolidating feasibility work
A gap-analysis study brought together previous Goongarrie work. The KalGold spin-out was being prepared; a later completion summary is not backdated into June 2021.
ASX: ARL · Five-year financial review
(ASX: ARL) Ardea Resources Financial Review - FY2021~25
Ardea’s financial story is the funding and development of the Goongarrie nickel-cobalt project, not realised nickel sales. Consortium support changed the funding model in FY2025, while an R&D accounting change altered the reported loss and exploration-asset balances.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
FY2025 cash
A$14.684m
Consolidated closing balance.
FY2025 net loss
A$3.259m
Not the cost of the entire DFS.
Exploration carrying value
A$105.149m
Book cost, not project market value.
Consortium DFS budget
Up to A$98.5m
Project funding commitment, not free corporate cash.
Five years in context
Ardea narrowed its portfolio through the KalGold gold-rights spin-out and progressed the Goongarrie feasibility work. Study production targets, projected project returns and estimated mine life remain forward-looking; they are not recorded revenue, operating profit or historical production.
The later consortium arrangement funds the DFS through KNPL. A liability recorded before subsidiary shares were issued became equity after year-end, with Ardea retaining control. This timing distinction is more useful than describing the group simply as debt-free.
Events behind the numbers
FY2022
Capital raise and gold-rights spin-out
A substantial capital raise supported the nickel development strategy. The KalGold spin-out was completed, while the project gained Major Project Status and Emu Lake exploration progressed.
FY2023
PFS work and partner selection
Cash funded exploration and feasibility studies. The PFS and Japanese consortium memorandum announced in July 2023 belong to the subsequent reporting period, not realised FY2023 sales.
FY2024
Consortium cooperation agreed
The April 2024 cooperation arrangement progressed the DFS funding plan. FIRB approval and the binding shareholders’ agreement followed in August, after the June balance date.
FY2025
DFS funding and strategic investment
The binding joint venture agreement took effect in August 2024, and Sumitomo invested in Ardea shares. The consortium’s first 17.5% KNPL equity interest was issued on 4 July 2025.
FINANCIAL REVIEW / 01
The loss narrowed, but operating cash use increased
The latest loss is smaller than the restated FY2024 figure, while operating cash outflow is larger. Recognition timing, non-cash expenses and receivable movements prevent a direct loss-to-cash equivalence.
Closing cash
A$ million
Closing cash
AI-generated presentation · values from Five-year earnings and cash record; no missing values plotted as zero.
Net loss and operating cash
A$ million
Net lossOperating cash flow
AI-generated presentation · values from Five-year earnings and cash record; no missing values plotted as zero.
Five-year earnings and cash record
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net loss | (2.299) | (5.328) | (4.236) | (6.462) | (3.259) |
| Closing cash | 5.690 | 22.018 | 10.648 | 14.849 | 14.684 |
| Operating cash flow | (0.555) | (2.065) | (1.370) | (4.135) | (6.119) |
Years ended 30 June; A$ million. FY2024 earnings use the FY2025 restated comparative. Earlier earnings retain their original annual-report basis.
R&D incentives changed from a deduction against capitalised exploration to income. The five-year loss series is not uniformly restated and no earnings-growth rate is calculated.
Operating cash is not total project spending: capitalised exploration payments were historically classified as investing.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 02
A large current liability became subsidiary equity after June
The statement records A$49.476m of current borrowings at June 2025. The dated transaction note identifies A$49.25m for the July equity conversion; rounded narrative funding totals vary, so they are not treated as exact interchangeable balances.
The subsequent earn-in did not generate profit or goodwill and did not end consolidation of KNPL. Further FEED or pre-construction funding may still require Ardea participation, with dilution if it elects not to contribute.
Exploration book value and equity
A$ million
Capitalised exploration and evaluationNet assets / total equity
AI-generated presentation · values from The latest balance sheet includes the consortium advance; no missing values plotted as zero.
The latest balance sheet includes the consortium advance
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Capitalised exploration and evaluation | 52.968 | 105.149 |
| Total assets | 70.706 | 125.369 |
| Current borrowings | 0.904 | 49.476 |
| Total liabilities | 4.611 | 57.739 |
| Net assets / total equity | 66.096 | 67.630 |
| Working capital / (deficit) | 12.412 | (38.148) |
FY2024 is restated for the R&D accounting-policy change.
The FY2025 current liability includes investor funding awaiting conversion to subsidiary equity after year-end. The calculated deficit does not by itself establish an immediate cash repayment demand.
A$49.25m was reclassified from liability to equity on 4 July 2025. Do not make that July entry in the June balance sheet.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 03
R&D restatement changed earnings, not the bank balance
Under the revised policy, qualifying incentives are recognised in other income rather than deducted from exploration assets. The FY2024 comparative is restated, and the policy change itself has no cash-flow impact. Refund cash, accrued income and a receivable must remain separate.
Write-offs and share-based payments
A$ million
Exploration write-offs / impairmentShare-based payment expense
AI-generated presentation · values from Selected non-cash expenses behind the loss; no missing values plotted as zero.
What the R&D policy change did to FY2024
A$ million
| Metric | FY2024 previously reported | FY2024 restated |
|---|---|---|
| Other income | 0.934 | 2.177 |
| Loss before tax | (7.705) | (6.462) |
| Capitalised exploration balance | 42.885 | 52.968 |
| Other receivables | 0.996 | 1.837 |
Restatement changes recognition and carrying values, not cash flows.
The exploration-balance adjustment includes historical R&D recognition changes; it is not new drilling expenditure in FY2024.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Selected non-cash expenses behind the loss
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Exploration write-offs / impairment | 0.424 | 0.223 | 0.787 | 1.532 | 0.466 |
| Share-based payment expense | 0.244 | 0.374 | 1.095 | 1.994 | 0.433 |
Positive expense magnitudes. These are components of loss, not extra cash outflows.
Capitalised exploration expenditure is not charged immediately as exploration expense; write-offs and share payments alone do not explain the whole loss.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 04
Cash investment preceded the larger earn-in programme
Earlier capital raises financed substantial exploration payments. The later A$98.5m DFS budget is a programme commitment and does not mean Ardea holds that sum as unrestricted cash or that construction finance has been secured.
Exploration cash payments before FY2024
A$ million
Exploration and evaluation payments
AI-generated presentation · values from Cash deployment before the consortium-funded DFS; no missing values plotted as zero.
Cash deployment before the consortium-funded DFS
A$ million
| Metric | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Exploration and evaluation payments | (9.579) | (8.255) | (11.870) |
| R&D refunds received | 1.040 | 0.893 | 1.941 |
| Total investing cash flow | (8.405) | (7.283) | (9.996) |
| Gross share-issue cash | 4.874 | 27.335 | 0.000 |
| Net financing cash flow | 4.643 | 25.677 | (0.005) |
Total investing includes the exploration and refund rows; do not add components to the total.
FY2023 nil share proceeds and the A$5,000 financing outflow reflect the extracted cash statement; they are not a missing-data substitution.
A comparable full FY2024-FY2025 investing/financing cash breakdown is not supplied in the selected packet and is not reconstructed from funding commitments.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 05
Feasibility progress is not operating-mine revenue
At this stage, study quality, delivery against the funded budget and the next funding decision are more informative than a manufactured production or sales trend. The group described its activities as exploration and feasibility studies, and future construction remained a distinct funding step.
Reading the figures
- Existing frozen annual extraction only. No original annual reports, new database queries, financial web research or MiniMax drafting. Published primary-author review.
- FY2021-FY2023 earnings retain their original editions; FY2024 is restated. No uniformly restated five-year return or growth rate is manufactured.
- The extracted narrative asserting no debt is not substituted for the dated consolidated borrowings statement. The investor advance and July conversion are explained separately.
- A small exploration-value narrative conflicts with the consolidated balance-sheet amount. The explicit consolidated A$105.149m row is selected; no unsupported ownership apportionment is applied.
- The selected packet lacks a complete comparable FY2024-FY2025 investing/financing cash breakdown. This is a packet limitation, not a claim that the issuer did not disclose one.
- The DFS budget, projected mine output and PFS valuation are not current cash, realised sales or project market value.
Annual-report source registry
- Ardea Resources - Minor Correction to the Annual ReportFrozen annual extraction; R&D restatement and consortium transaction timing preserved.
- Ardea Resources - Annual Report to shareholdersFrozen annual extraction; R&D restatement and consortium transaction timing preserved.
- Ardea Resources - Annual Report to shareholdersFrozen annual extraction; R&D restatement and consortium transaction timing preserved.
- Ardea Resources - Annual Report to shareholdersFrozen annual extraction; R&D restatement and consortium transaction timing preserved.
- Ardea Resources - Annual Report to shareholdersFrozen annual extraction; R&D restatement and consortium transaction timing preserved.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.